IP Library Granted Patent US 8,153,743
Granted Patent B2
US 8,153,743 · App. 12/183,295 · Granted Apr 10, 2012

Controlled exotherm of cyanoacrylate formulations

Assignee: Closure Medical Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,153,743
App. No.
12/183,295
Granted
Apr 10, 2012
Kind
B2
Abstract

An adhesive composition includes one or more polymerizable cyanoacrylate monomers, a polymerization initiator and a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers. A system for treating living tissue includes a first reservoir containing one or more polymerizable cyanoacrylate monomers, a second reservoir in a non-contacting relationship with the first reservoir containing a polymerization initiator and accelerator for the one or more polymerizable cyanoacrylate monomers, and an applicator capable of combining the polymerizable cyanoacrylate monomer and the polymerization initiator and accelerator to form an adhesive composition and then applying the adhesive composition to living tissue. The initiator may be a quaternary ammonium salt, and the accelerator may be a trihydroxy tertiary amine.

Claims (31)

1. An adhesive composition comprising:

one or more polymerizable cyanoacrylate monomers,

a polymerization initiator for the one or more polymerizable cyanoacrylate monomers comprising a quaternary ammonium salt, and

a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers comprising a trihydroxy tertiary amine,

wherein the trihydroxy tertiary amine comprises a compound according to formula C:

wherein R 8 , R 9 , R 10 , R 11 , R 12 , R 13 are each, independently a C1-C20 alkylene, substituted alkylene, cyclic or substituted cycloalkylene, or aryl group.

2. The adhesive composition of claim 1 , wherein the quaternary ammonium salt comprises a compound according to formula A:

wherein R 1 , R 2 , R 3 and R 4 are each, independently, a substituted or unsubstituted straight, branched or cyclic alkyl group; a substituted or unsubstituted aromatic ring; or a substituted or unsubstituted aralkyl group, wherein the alkyl groups, aromatic rings or aralkyl groups may optionally further contain heteroatoms; and X − is an anion.

3. The adhesive composition of claim 1 , wherein the quaternary ammonium salt is benzalkonium chloride.

4. An adhesive composition comprising:

one or more polymerizable cyanoacrylate monomers,

a polymerization initiator for the one or more polymerizable cyanoacrylate monomers comprising a quaternary ammonium salt, and

a polymerization accelerator for the one or more polymerizable cyanocrylate monomers comprising a trihydroxy tertiary amine wherein the trihydroxy tertiary amine

is poly (5) oxyethylene isotridecyloxypropyl amine .

5. A system for treating living tissue comprising:

a first reservoir containing one or more polymerizable cyanoacrylate monomers,

a second reservoir in a non-contacting relationship with the first reservoir containing a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers comprising a trihydroxy tertiary amine, wherein the trihydroxy tertiary amine comprises a compound according to formula C:

wherein R 8 , R 9 ,R 10 ,R 11 ,R 12 ,R 13 are each, independently a C1-C20 alkylene,

substituted alkylene, cyclic or substituted cycloalkylene, or aryl group and

an applicator capable of combining the polymerizable cyanoacrylate monomer and the polymerization accelerator to form an adhesive composition and then applying the adhesive composition to living tissue.

6. The system of claim 5 , further comprising a polymerization initiator for the one or more polymerizable cyanoacrylate monomers comprising a quaternary ammonium salt, wherein the polymerization initiator is disposed in the second reservoir with the polymerization accelerator.

7. The system of claim 6 , wherein the quaternary ammonium salt comprises a compound according to formula A:

wherein R 1 , R 2 , R 3 and R 4 are each, independently, a substituted or unsubstituted straight, branched or cyclic alkyl group; a substituted or unsubstituted aromatic ring; or a substituted or unsubstituted aralkyl group, wherein the alkyl groups, aromatic rings or aralkyl groups may optionally further contain heteroatoms; and X − is an anion.

8. The system of claim 6 , wherein the quaternary ammonium salt is benzalkonium chloride.

9. A system for treating living tissue comprising:

a first reservoir containing one or more polymerizable cyanoacrylate monomers,

a second reservoir in a non-contacting relationship with the first reservoir containing a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers comprising a trihydroxy tertiary amine, wherein the trihydroxy tertiary

amine is poly (5) oxyethylene isotridecyloxypropyl amine and

an applicator capable of combining the polymerizable cyanoacrylate monomer and the polymerization accelerator to form an adhesive composition and then applying the adhesive composition to living tissue.

10. A method of treating living tissue, comprising:

applying to living tissue a biocompatible adhesive composition comprising one or more polymerizable cyanoacrylate monomers, a polymerization initiator for the one or more polymerizable cyanoacrylate monomers comprising a quaternary ammonium salt, and a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers comprising a trihydroxy tertiary amine, wherein the polymerization accelerator is poly (5) oxyethylene isotridecyloxypropyl amine.

Assignments (2)
CHANGE OF NAME Recorded Apr 18, 2012
From: CLOSURE MEDICAL CORPORATION
To: ETHICON, INC.
Reel/Frame 028065/0989 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2008
From: BADEJO, IBRAHEEN T; RIVERA, ANDRES; VANDER KLOK, MELANIE
To: CLOSURE MEDICAL CORPORATION
Reel/Frame 021642/0761 →
Continuity (1)
Related Publication 20100030258A1 · Feb 4, 2010